RGC·G7487R100·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
ORDINARY SHARES
RGC (REGENCELL BIOSCIENCE HLDGS L) is held by 13 institutional investors as of Q4 2025. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($8.7M), Vident Advisory, LLC ($628,614), Squarepoint Ops LLC ($546,231). Net institutional sentiment: Mixed.
See how RGC's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer